Aisling Capital as of Dec. 31, 2015
Portfolio Holdings for Aisling Capital
Aisling Capital holds 22 positions in its portfolio as reported in the December 2015 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Loxo Oncology | 18.6 | $108M | 3.8M | 28.45 | |
| Cempra | 11.8 | $68M | 2.2M | 31.13 | |
| Zeltiq Aesthetics | 10.3 | $60M | 2.1M | 28.53 | |
| Aimmune Therapeutics | 9.5 | $55M | 3.0M | 18.45 | |
| Esperion Therapeutics (ESPR) | 6.3 | $36M | 1.6M | 22.26 | |
| T2 Biosystems | 5.3 | $31M | 2.8M | 10.94 | |
| Agile Therapeutics | 5.0 | $29M | 3.0M | 9.76 | |
| Adma Biologics (ADMA) | 5.0 | $29M | 3.6M | 8.07 | |
| Dermira | 4.9 | $28M | 821k | 34.61 | |
| Versartis | 4.9 | $28M | 2.3M | 12.39 | |
| Transenterix | 3.6 | $21M | 8.3M | 2.48 | |
| Catalent | 3.1 | $18M | 716k | 25.03 | |
| Cidara Therapeutics Inc Common Stock Usd 0.0001 | 3.0 | $18M | 1.0M | 17.16 | |
| Cynapsus Therapeutics | 2.7 | $16M | 1.0M | 15.29 | |
| Paratek Pharmaceuticals | 2.2 | $13M | 683k | 18.97 | |
| Intersect Ent | 1.4 | $7.9M | 350k | 22.50 | |
| Pernix Therapeutics Holdings | 1.0 | $5.9M | 2.0M | 2.95 | |
| Chimerix (CMRX) | 0.7 | $4.2M | 473k | 8.95 | |
| Pernix Therapeutics Hldgs In debt | 0.2 | $1.5M | 2.5M | 0.58 | |
| Lombard Med (EVARF) | 0.2 | $1.2M | 886k | 1.35 | |
| Roka Bioscience | 0.1 | $704k | 573k | 1.23 | |
| Sorrento Therapeutics (SRNE) | 0.0 | $34k | 3.9k | 8.82 |
